Teresa
Lozano Moreda
Profesional Investigadora
Publications by the researcher in collaboration with Teresa Lozano Moreda (16)
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2022
-
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy
OncoImmunology, Vol. 11, Núm. 1
-
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
Cancer Letters, Vol. 528, pp. 45-58
2020
-
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
Journal for immunotherapy of cancer, Vol. 8, Núm. 1
2019
-
Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies
Frontiers in Immunology, Vol. 10
-
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
Molecular Therapy, Vol. 27, Núm. 11, pp. 1878-1891
-
Therapeutic Effect of Irreversible Electroporation in Combination with Poly-ICLC Adjuvant in Preclinical Models of Hepatocellular Carcinoma
Journal of Vascular and Interventional Radiology, Vol. 30, Núm. 7, pp. 1098-1105
2018
-
Immunomodulatory properties of carvone inhalation and its effects on contextual fear memory in mice
Frontiers in Immunology, Vol. 9, Núm. JAN
-
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
OncoImmunology, Vol. 7, Núm. 4
2017
-
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
Oncotarget, Vol. 8, Núm. 42, pp. 71709-71724
-
Expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy
Cancer Research, Vol. 77, Núm. 13, pp. 3672-3684
2015
-
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation
Journal of Immunology, Vol. 195, Núm. 7, pp. 3180-3189
2013
-
A fusion protein between streptavidin and the endogenous tlr4 ligand EDA targets biotinylated antigens to dendritic cells and induces t cell responses in vivo
BioMed Research International, Vol. 2013
2012
-
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
Vaccine, Vol. 30, Núm. 18, pp. 2848-2858
-
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
International Journal of Cancer, Vol. 131, Núm. 3, pp. 641-651
2010
-
A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice
Journal of Immunology, Vol. 185, Núm. 9, pp. 5150-5159